The past 10 years' experience with bone marrow transplantation from normal, immunologically compatible donors indicates its possible use in various neurometabolic diseases, particularly in a patient who has not suffered irreparable brain damage. This experience may be a prelude to treatment by somatic gene therapy. This can be applied as an autologous bone marrow transplant, grafting the patient's own stem cells inserted with the normal gene. Although somatic gene therapy will be relatively easy for tissues with dividing cells, its application to target tissues with little or no cell division may pose difficulties. Meanwhile, techniques for the preservation, culture, and grafting of fetal neurons in humans have been developed and have been used in the treatment of Parkinson's disease. These procedures could readily be transferred to the treatment of other neurodegenerative diseases that cause significant morbidity, but ethical, legal, and religious considerations must be taken into account. All these efforts promise novel and improved management of inborn neurometabolic errors. (J Child Neurol 1992;7(Suppl):S132-S140.)
Get full access to this article
View all access options for this article.
References
1.
Baird PA, Anderson TW, Newcombe HB, Lowry RB: Genetic disorders in children and young adults: A population study . Am J Hum Genet1988;42:677-693.
2.
Ozand PT, DeVol E., Gascon GG: Neurometabolic diseases at a national referral center: Five years experience at the King Faisal Specialist Hospital and Research Centre. J Child Neurol1992;7(Suppl):S4-S11.
3.
Hobbs JR: Displacement bone marrow transplantation for some inborn errors. J Inherited Metab Dis1990;13:572-596.
4.
Yeager AM: Bone marrow transplantation in children. Pediatr Ann1988;17:694-714.
5.
Neufeld EF: The uptake of enzymes into lysosomes: An overview. Birth Defects1980;16:77-84.
6.
Abraham D., Muir H., Olsen I., Winchester B.: Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease . Biochem Biophys Res Commun1985;12:415-417.
7.
Blazar BR, Whitley CB, Desnick RJ, et al: Comparison of enzymatic activity with evidence of engraftment in patients with inborn errors of metabolism receiving allogeneic bone marrow transplantation. Birth Defects1986;22:132-152.
8.
Konigsmark BW , Sidman RL: Origin of brain macrophages in the mouse . J Neuropathol Exp Neurol1983;22:643-648.
9.
Hickey WF, Kimura H.: Perivascular microglial cells of the CNS are bone-marrow derived and present antigen in vivo. Science1988;239:290-292.
10.
Krivit W., Lipton ME, Lockman LA, et al: Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am J Med Sci1987;294:80-85.
11.
Krivit W., Whitley CB, Chang P-N., et al: Lysosomal storage diseases treated by bone marrow transplantation: A report from the University of Minnesota Variety Club Children's Hospital , in Gale RP, Champlin RE (eds): Bone Marrow Transplantation: Current Controversies. New York, Alan Liss , 1989, pp 367-378.
12.
Krivit W., Whitley CB, Chang P-N., et al: Lysosomal storage diseases treated by bone marrow transplantation: Review of 21 patients, in Johnson FL, Pochedly C (eds): Bone Marrow Transplantation in Children. New York, Raven Press , 1990, pp 261-287.
13.
Hobbs JR: Experience with bone marrow transplantation for inborn errors of metabolism . Enzyme1987;38:194-206.
14.
Yam PY, Petz LD, Knowlton RJ, et al: Use of DNA restriction fragment length polymorphisms to document bone marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation1987;43: 399-407.
15.
Min GL, Hibbin J., Arthur C., et al: Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. Br J Haematol1988;68:195-201.
16.
Summers CG, Purple RL, Krivit W., et al: Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. Ophthalmology1989;96:977-985.
17.
Whitley CB, Ramsay NKC, Kersey JH, Krivit W.: Bone marrow transplantation for Hurler syndrome: Assessment of metabolic correction . Birth Defects1986;22:7-24.
18.
Hobbs JR, Hugh-Jones K., Barrett AJ, et al: Reversal of clinical features of Hurler's disease and biochemical improvement after treatment of bone-marrow transplantation. Lancet1981;2: 709-712.
19.
Hugh-Jones K.: Psychomotor development of children with mucopolysaccharidosis type 1-H following bone marrow transplantation, in Krivit W, Paul NW (eds): Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases, vol 22. New York, Alan R Liss, 1986, pp 25-29.
20.
Whitley CB, Gorlin RJ, Krivit W.: A nonpathologic allele (IW) for low L-alpha-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler's syndrome. Am J Med Genet1987;28: 233-243.
21.
Clink HM, Ozand PT, Ernst P., et al: A case of Morquio's disease type A successfully treated by bone marrow transplantation, abstract. Bone Marrow Transplant1990;5(Suppl 2):204.
22.
Krivit W., Pierpont ME, Ayaz K., et al: Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). N Engl J Med1984;311:1606-1611.
23.
McGovern MM , Ludman MD, Short MP, et al: Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): Status 40 months after BMT. Birth Defects1986;22:41-53.
24.
Ringden O., Groth C-G., Erikson A., et al: Long-term follow-up of the first successful bone marrow transplantation in Gaucher's disease. Transplantation1988 ;46:66-70.
25.
Starer F., Sargent JD, Hobbs JR: Regression of the radiological changes of Gaucher's disease following bone marrow transplantation. Br J Radiol1987 ;60:1189-1195.
26.
Rappeport JM , Barranger JA, Ginns EI: Bone marrow transplantation in Gaucher disease . Birth Defects1986;22: 101-109.
27.
Barton NW, Fusrbish FC, Murray GJ, et al: Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA1990;87: 1913-1916.
28.
Zimran A., Sorge J., Gross E., et al: A glucocerebrosidase fusion gene in Gaucher disease. Clin Invest1990;85:219-222.
29.
Bayever E., Philippart M., Nuwer M., et al: Bone marrow transplantation for metachromatic leukodystrophy . Lancet1985;2: 471-473.
30.
Stein C., Gieselmann V., Kreysing J.: Cloning and expression of human arylsulfatase A. J Biol Chem1989;261:1252-1259.
31.
Ladisch S., Bayever E., Pjilippart M., Feig SA: Biochemical findings after bone marrow transplantation for metachromatic leukodystrophy: A preliminary report. Birth Defects1986;22: 69-76.
32.
Weinber K., Moser A., Watkins P., et al: Bone marrow transplantation (BMT) for adrenoleukodystrophy (ALD) . Pediatr Res1988;23:334A.
33.
Yeager AM, Moser HW, Tutschka PJ, et al: Allogeneic bone marrow transplantation in adrenoleukodystrophy: Clinical, pathologic, and biochemical studies. Birth Defects1986;22: 79-100.
34.
Aubourg P., Blanch S., Jambaque I., et al: Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone-marrow transplantation. N Engl J Med1990;322:1860-1866.
35.
Moser AB, Borel J., Odone A., et al: A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patients. Ann Neurol1987;21:240-249.
36.
Rizzo WB, Leshner RT, Odone A., et al: Dietary erucic acid therapy for X-linked adrenoleukodystrophy . Neurology1989;39:1415-1422.
37.
Vellodi A., Hobbs JRF, O'Donnell NM, et al: Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation. Br Med J1987;295:1375-1376.
38.
Harris RE, Hannon D., Vogler C., Hug G.: Bone marrow transplantation in type IIa glycogen storage disease. Birth Defects1987;22:119-132.
39.
Adachi M., Schneck L., Volk BW: Ultrastructural studies of eight cases of fetal Tay-Sachs disease . Lab Invest1974;30:102-112.
40.
Linch DC, Rodeck CH, Nicolaides K., et al: Attempted bone-marrow transplantation in a 17 week fetus. Lancet1986;2:1453.
41.
Perry VH, Hume DA, Gordon S.: Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neurosciences1985;15:313-326.
42.
Ledley FD: Clinical application of somatic gene therapy in inborn errors of metabolism . J Inherited Metab Dis1990;13:597-616.
43.
Kohn DB, Anderson WF, Blaese RM: Gene therapy for genetic diseases. Cancer Invest1989;7:179-192.
44.
Bernstein A. , Dick JE, Huszarf D., et al: Genetic engineering of mouse and human stem cells. Cold Spring Harb Symp Quant Biol1986;51:1083-1091.
45.
Miller AD, Palmer TD, Hock RA: Transfer of genes into human somatic cells using retrovirus vectors . Cold Spring Harb Symp Quant Biol1986;51:1013-1019.
46.
Bordignon C. , Yu SF, Smith CA, et al: Retroviral vector mediated high efficiency expression of adenosine deaminase in haematopoietic long term cultures of ADA deficient marrow cells. Proc Natl Acad Sci USA1989;86:6748-6752.
47.
Teich N., Wyke J., Mak T., et al: Pathogenesis of retroviral induced genes, in Weiss R, Teich N , Varmus H, Coffin J (eds): RNA Tumor Viruses: Molecular Biology of Tumor Viruses. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1984, pp 785-998.
48.
Keller G., Wagner EF: Efficient expression of foreign genes in mice reconstituted with retrovirus-infected bone marrow cells. Cold Spring Harb Symp Quant Biol1986;51:1053-1058.
49.
Sorge J., Kuhl W., West C., Beutler E.: Gaucher disease: Retrovirus-mediated correction of the enzymatic defect in cultured cells. Cold Spring Harb Symp Quant Biol1986;51: 1041-1046.
50.
Choudary PV , Tsuji S., Martin BM, et al: The molecular biology of Gaucher disease and the potential for gene therapy. Cold Spring Harb Symp Quant Biol1986;51:1047-1052.
51.
Kyle JW, Birkenmeier EH, Gwynn B., et al: Correction of murine mucopolysaccharidosis VII by a human betaglucuronidase transgene. Proc Natl Acad Sci USA1990;87: 3914-3918.
52.
Thomas KR, Capecchi MR: Targeting of genes to specific sites in the mammalian genome. Cold Spring Harb Symp Quant Biol1986;51:1101-1113.
53.
Akhurst RJ: Prospects for gene therapy now and in the future. J Inherited Metab Dis1989;12(Suppl 1):191-201.
54.
Ledley FD: Somatic gene therapy for human disease: A problem of eugenics?Trends Genet1987;3:112-115.
55.
Lenarsky C. , Kohn DB, Weinberg KI, Parkman R.: Bone marrow transplantation for genetic diseases . Hematol Oncol Clin North Am1990;4:589-602.
56.
Williams DA , Orkin SH, Mulligan RC: Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci USA1986 ;83:2566--2570.
57.
Belmont JW, MacGregor CR, Wager-Smith K., et al: Expression of human adenosine deaminase in murine hematopoietic cells. Mol Cell Biol1988;8:5116-5125.
58.
Dzierzak EA, Papayannopoulou T., Mulligan RC: Lineage-specific expression of human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells . Nature1988;331:35-41.
59.
Peng H., Armentano D., Graham L., et al: Tissue specific expression of human phenylalanine hydroxylase in mouse hepatocytes following retroviral mediated gene transfer. Proc Natl Acad Sci USA1988;85:8146-8150.
60.
Nyhan WL, Page T., Gruber HE, Parkman R.: Bone marrow transplantation in Lesch-Nyhan disease. Birth Defects1986;22: 113-117.
61.
Rosenberg MB , Friedmann T., Robertson RC, et al: Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression . Science1988;242:1575-1578.
62.
Lee CC, Wu XW, Gibbs RA, et al: Generation of cDNA probes directed by amino acid sequence: Cloning of urate oxidase. Science1988;239:1288-1291.
63.
Nelson DL, Chang SMW, Henkel-Tigges J., et al: Gene replacement therapy for inborn errors of purine metabolism . Cold Spring Harb Symp Quant Biol1986;51:1065-1071.
64.
Cournoyer D. , Scarpa M., Jones SN, et al: Gene therapy: A new approach for the treatment of genetic disorders. Clin Pharmacol Ther1990;47:1-11.
65.
Barinaga M. : Playing tetherball in the nervous system. Science1990;250:506-507.
Bjorklund A. , Brundin P., Isacson O.: Neuronal replacement by intracerebral neural implants in animal models of neurodegenerative disease . Adv Neurol1988;47:455-492.
69.
Gage FH, Bjorklund A.: Enhanced graft survival in the hippocampus following selective denervation . Neuroscience1986;17: 89-98.
70.
Bjorklund A. , Segal M., Stenevi U.: Functional reinnervation of rat hippocampus by locus coeruleus implants. Brain Res1979 ;170:409-426.
71.
Segal M., Greenberger V., Milgram MW: A functional analysis of connections between grafted septal nuclei and a host hippocampus. Prog Brain Res1986 ;71:349-357.
72.
Collier TJ, Gash DM, Sladek JRJr: Transplantation of norepinephrine neurons into aged rats improves performance of a learned task. Brain Res1988 ;448:77-87.
73.
Backlund E-O. , Granber P-O., Hamberger P., et al: Transplantation of adrenal medullary tissue to the striatum in parkinsonism. First clinical trials. J Neurosurg1985;62:169-173.
74.
Redmond DE, Sladek JR, Roth RH, et al: Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine . Lancet1986;1:1125-1127.
75.
Lindvall O. , Brundin P., Widner H., et al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease . Science1990;247:574-577.
76.
Wictorin K. , Brundin P., Gustavii B., et al: Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature1990;347:556-558.
77.
Cattaneo E. , McKay R.: Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature1990;347:762-765.
78.
Brundin P., Nilsson OG, Gage FH, Bjorklund A.: Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res1985;60: 204-208.
79.
Collier TJ, Redmond DE, Sladek CD, et al: Intracerebral grafting and culture of cryopreserved primate dopamine neurons. Brain Res1987;436:363-366.
80.
Mattson MP, Rychlik B.: Cell culture of cryopreserved human fetal cerebral, cortical, and hippocampal neurons: Neuronal development and responses to trophic factors . Brain Res1990;522:204-214.
81.
Silani V., Pizutti A., Strada O., et al: Human neuronal cell viability demonstrated in culture after cryopreservation. Brain Res1988;473:169-174.
